X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (431) 431
Publication (82) 82
Conference Proceeding (36) 36
Book Review (32) 32
Patent (5) 5
Book / eBook (3) 3
Book Chapter (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (226) 226
humans (219) 219
oncology (195) 195
male (129) 129
female (125) 125
melanoma (118) 118
middle aged (115) 115
aged (111) 111
adult (104) 104
melanoma - drug therapy (96) 96
cancer (76) 76
article (68) 68
treatment outcome (59) 59
melanoma - pathology (56) 56
metastatic melanoma (54) 54
mutation (52) 52
aged, 80 and over (51) 51
immunotherapy (51) 51
melanoma - genetics (50) 50
proto-oncogene proteins b-raf - genetics (41) 41
abridged index medicus (40) 40
antineoplastic agents - therapeutic use (38) 38
antineoplastic combined chemotherapy protocols - therapeutic use (37) 37
skin neoplasms - drug therapy (36) 36
ipilimumab (33) 33
survival (33) 33
disease-free survival (32) 32
skin neoplasms - pathology (31) 31
vemurafenib (29) 29
care and treatment (28) 28
antibodies, monoclonal - therapeutic use (27) 27
kidney neoplasms - drug therapy (27) 27
research (27) 27
antineoplastic combined chemotherapy protocols - adverse effects (26) 26
braf (26) 26
proto-oncogene proteins b-raf - antagonists & inhibitors (26) 26
therapy (26) 26
animals (25) 25
carcinoma, renal cell - drug therapy (25) 25
dose-response relationship, drug (24) 24
immunology (24) 24
melanoma - therapy (24) 24
nivolumab (24) 24
antineoplastic agents - adverse effects (23) 23
chemotherapy (23) 23
malignant-melanoma (23) 23
metastasis (23) 23
protein kinase inhibitors - therapeutic use (23) 23
health aspects (22) 22
neoplasm staging (22) 22
drug therapy (21) 21
melanoma - immunology (21) 21
prognosis (21) 21
skin neoplasms - genetics (21) 21
tumors (21) 21
antibodies, monoclonal - adverse effects (20) 20
cell line, tumor (20) 20
clinical trials (20) 20
interleukin-2 - administration & dosage (20) 20
melanoma - mortality (20) 20
neoplasm metastasis (20) 20
cell lung-cancer (19) 19
interleukin-2 (19) 19
kaplan-meier estimate (19) 19
medicine, general & internal (19) 19
cell biology (18) 18
drug administration schedule (18) 18
melanoma - secondary (18) 18
open-label (18) 18
trial (18) 18
indoles - therapeutic use (17) 17
mutations (17) 17
neoplasms - drug therapy (17) 17
safety (17) 17
survival rate (17) 17
interleukin-2 - therapeutic use (16) 16
melanoma - metabolism (16) 16
mice (16) 16
pathway (16) 16
patients (16) 16
acquired-resistance (15) 15
antineoplastic agents - administration & dosage (15) 15
cells (15) 15
follow-up studies (15) 15
phase-ii (15) 15
bevacizumab (14) 14
disease progression (14) 14
genetic aspects (14) 14
interleukin-2 - adverse effects (14) 14
kidney neoplasms - pathology (14) 14
neoplasms (14) 14
sulfonamides - therapeutic use (14) 14
time factors (14) 14
antineoplastic agents - pharmacology (13) 13
carcinoma, renal cell - mortality (13) 13
dosage and administration (13) 13
kidney neoplasms - mortality (13) 13
medicine, research & experimental (13) 13
pd-1 blockade (13) 13
pembrolizumab (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 09/2015, Volume 21, Issue 17 Supplement, pp. IA15 - IA15
Journal Article
Cancer Research, ISSN 0008-5472, 07/2015, Volume 75, Issue 14 Supplement, pp. IA13 - IA13
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2012, Volume 366, Issue 8, pp. 707 - 714
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 10/2019, Volume 105, Issue 2, pp. 245 - 246
Journal Article
The Lancet Oncology, ISSN 1470-2045, 03/2018, Volume 19, Issue 3, pp. 310 - 322
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2010, Volume 363, Issue 8, pp. 711 - 723
Journal Article
The Lancet, ISSN 0140-6736, 03/2018, Volume 391, Issue 10124, pp. 933 - 933
Immune checkpoint inhibitors have greatly improved clinical outcomes in multiple cancer types and are increasingly being used in earlier disease settings and... 
MEDICINE, GENERAL & INTERNAL | CARDIOTOXICITY | Myocarditis | Fatalities | Heart diseases | Melanoma | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 19, pp. 1803 - 1813
Journal Article